CDK2 and neoplasm: Silymarin upregulates Kip1/p27 and Cip1/p21 expression in tumors, which decreases the protein levels of CDK2, CDK4, Cyclin E, Cyclin A, and Cyclin D1, ultimately leading to tumor cell cycle arrest and reduce proliferation (Fotedar et al., 2004).